NMRD OTC
Nemaura Medical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$8M
-29.9% ▼
Capital Expenditures
$539K
+43.6% ▲
5Y CAGR: +64.1%
Free Cash Flow
-$9M
-20.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
+45.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$4M | -$6M | -$14M | -$14M |
| Depreciation & Amort. | $33K | $55K | $98K | $230K | $444K |
| Stock-Based Comp. | $430K | $565K | $113K | $221K | $0 |
| Change in Working Capital | $394K | $78K | -$2M | -$175K | -$2M |
| Other Non-Cash Items | $35K | $13K | $2M | $7M | $7M |
| Operating Cash Flow | -$4M | -$3M | -$6M | -$7M | -$8M |
| — Investing Activities — | |||||
| Capital Expenditures | -$80K | -$211K | -$836K | -$956K | -$376K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $4M | $0 | $0 | $0 | $0 |
| Other Investing | $4M | $0 | $0 | $0 | -$163K |
| Investing Cash Flow | $4M | -$211K | -$836K | -$956K | -$539K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $24M | -$12M | -$6M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$425K | -$55K | -$2M | $3M | -$738K |
| Financing Cash Flow | $2M | $97K | $38M | -$6M | $2M |
| Net Change in Cash | $3M | -$4M | $32M | -$14M | -$8M |
| Cash End of Period | $4M | $106K | $32M | $18M | $10M |
| Free Cash Flow | -$4M | -$4M | -$7M | -$7M | -$9M |